The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High efficiency transformation of E.coli by high voltage electroporation
Dower, W. J., Miller, J. F., & Ragsdale, C. W. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.13.6127 · Cited by 2,809
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., & Johnson, K. S. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-309 · Cited by 1,027
Isolation of high affinity human antibodies directly from large synthetic repertoires.
Griffiths, A. D., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., Kontermann, R. E., Jones, P. T., Low, N. M., & Allison, T. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06626.x · Cited by 962
"Diabodies": small bivalent and bispecific antibody fragments.
Holliger, P., Prospero, T., & Winter, G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6444 · Cited by 874
A synthetic IgG-binding domain based on staphylococcal protein A
Nilsson, B., Moks, T., Jansson, B., Abrahmsén, L., Elmblad, A., Holmgren, E., Henrichson, C., Jones, T. A., & Uhlén, M. (1987) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/1.2.107 · Cited by 759
Self-citationDirect solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support
Hultman, T., Stahl, S., Homes, E., & Uhlén, M. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.13.4937 · Cited by 723
Self-citationBy–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling
Marks, J. D., Griffiths, A. D., Malmqvist, M., Clackson, T. P., Bye, J. M., & Winter, G. (1992) · Nature Biotechnology · doi:10.1038/nbt0792-779 · Cited by 404
Sauer-Eriksson, A. E., Kleywegt, G. J., Uhlén, M., & Jones, T. A. (1995) · Structure · doi:10.1016/s0969-2126(01)00157-5 · Cited by 372
Self-citation
Cited by
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Molecularly Imprinted Polymers and Their Use in Biomimetic Sensors
Haupt, K., & Mosbach, K. (2000) · Chemical Reviews · doi:10.1021/cr990099w · Cited by 2,286
Engineering novel binding proteins from nonimmunoglobulin domains
Binz, H. K., Amstutz, P., & Plückthun, A. (2005) · Nature Biotechnology · doi:10.1038/nbt1127 · Cited by 676
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Self-citationLöfblom, J., Feldwisch, J., Tolmachev, V., Carlsson, J., Ståhl, S., & Frejd, F. Y. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.014 · Cited by 651
Self-citationBinz, H. K., Stumpp, M. T., Forrer, P., Amstutz, P., & Plückthun, A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00896-9 · Cited by 589
Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule
Orlova, A., Magnusson, M., Eriksson, T. L. J., Nilsson, M., Larsson, B., Höidén-Guthenberg, I., Widström, C., Carlsson, J., Tolmachev, V., Ståhl, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3521 · Cited by 568
Protein A chromatography for antibody purification
Hober, S., Nord, K., & Linhult, M. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.030 · Cited by 560
Self-citationEpidermal growth factor receptor targeting in cancer: a review of trends and strategies
Yewale, C., Baradia, D., Vhora, I., Patil, S., & Misra, A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.100 · Cited by 533
Antibody phage display technology and its applications
Hoogenboom, H. R., de Bruı̈ne, A. P., Hufton, S. E., Hoet, R. M., Arends, J.-W., & Roovers, R. C. (1998) · Immunotechnology · doi:10.1016/s1380-2933(98)00007-4 · Cited by 512
Microfluidic Chips for Point‐of‐Care Immunodiagnostics
Gervais, L., de Rooij, N., & Delamarche, E. (2011) · Advanced Materials · doi:10.1002/adma.201100464 · Cited by 491
Targeted nanoparticles for cancer therapy
Gu, F. X., Karnik, R., Wang, A. Z., Alexis, F., Levy-Nissenbaum, E., Hong, S., Langer, R. S., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 478
Biosensor technology: Technology push versus market pull
Luong, J. H. T., Male, K. B., & Glennon, J. D. (2008) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.05.007 · Cited by 454
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
Yin, H., & Hamilton, A. D. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461786 · Cited by 453
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
Hoyer, W., Grönwall, C., Jonsson, A., Ståhl, S., & Härd, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711731105 · Cited by 410
Self-citationCurrin, A., Swainston, N., Day, P. J., & Kell, D. B. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00351a · Cited by 388
Affibody Molecules in Biotechnological and Medical Applications
Ståhl, S., Gräslund, T., Eriksson Karlström, A., Frejd, F. Y., Nygren, P.-Å., & Löfblom, J. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2017.04.007 · Cited by 382
Self-citationNucleic Acid and Peptide Aptamers: Fundamentals and Bioanalytical Aspects
Mascini, M., Palchetti, I., & Tombelli, S. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201006630 · Cited by 374
Antibodies and Genetically Engineered Related Molecules: Production and Purification
Roque, A. C. A., Lowe, C. R., & Taipa, M. A. (2004) · Biotechnology Progress · doi:10.1021/bp030070k · Cited by 360
Iron oxide nanoparticles for targeted cancer imaging and diagnostics
Rosen, J. E., Chan, L., Shieh, D.-B., & Gu, F. X. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.08.017 · Cited by 329
Antibodies in diagnostics – from immunoassays to protein chips
Borrebaeck, C. A. K. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01683-2 · Cited by 324
LOVTRAP: an optogenetic system for photoinduced protein dissociation
Wang, H., Vilela, M., Winkler, A., Tarnawski, M., Schlichting, I., Yumerefendi, H., Kuhlman, B., Liu, R., Danuser, G., & Hahn, K. M. (2016) · Nature Methods · doi:10.1038/nmeth.3926 · Cited by 311
Sand, K. M. K., Bern, M., Nilsen, J., Noordzij, H. T., Sandlie, I., & Andersen, J. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00682 · Cited by 304
Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications
Zarschler, K., Rocks, L., Licciardello, N., Boselli, L., Polo, E., Garcia, K. P., De Cola, L., Stephan, H., & Dawson, K. A. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.02.019 · Cited by 303
Display of proteins on bacteria
Samuelson, P., Gunneriusson, E., Nygren, P.-Å., & Ståhl, S. (2002) · Journal of Biotechnology · doi:10.1016/s0168-1656(02)00043-3 · Cited by 295
Self-citationProgress in protein and antibody microarray technology
Angenendt, P. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03392-1 · Cited by 289
Xenaki, K. T., Oliveira, S., & van Bergen en Henegouwen, P. M. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01287 · Cited by 289
Nygren, P. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06438.x · Cited by 282
Self-citationSolid supports for microarray immunoassays
Kusnezow, W., & Hoheisel, J. D. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.625 · Cited by 277
Plastic antibodies: developments and applications
Haupt, K., & Mosbach, K. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01222-0 · Cited by 272
Research and development in biosensors
Scheller, F. W., Wollenberger, U., Warsinke, A., & Lisdat, F. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00169-5 · Cited by 267
Nilsson, P., Paavilainen, L., Larsson, K., Ödling, J., Sundberg, M., Andersson, A., Kampf, C., Persson, A., Szigyarto, C. A., Ottosson, J., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500072 · Cited by 265
Nanobodies: Chemical Functionalization Strategies and Intracellular Applications
Schumacher, D., Helma, J., Schneider, A. F. L., Leonhardt, H., & Hackenberger, C. P. R. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201708459 · Cited by 260
Affibody molecules as engineered protein drugs
Frejd, F. Y., & Kim, K.-T. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.35 · Cited by 225
Koide, A., Wojcik, J., Gilbreth, R. N., Hoey, R. J., & Koide, S. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.019 · Cited by 227
Live‐cell super‐resolution imaging of actin using LifeAct ‐14 with a PAINT ‐based approach
Bhaskar, H., Kleinjan, D., Oi, C., Gidden, Z., Rosser, S. J., Horrocks, M. H., & Regan, L. (2023) · Protein Science · doi:10.1002/pro.4558 · Cited by 12
Metadata
- Authors
- Nord, K., Gunneriusson, E., Ringdahl, J., Ståhl, S., Uhlén, M., & Nygren, P.-Å.
- Venue
- Nature Biotechnology
- Published
- 1997-08
- Volume
- 15
- Issue
- 8
- Pages
- 772-777
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2035758624
- Cited by
- 662
- References
- 34
- FWCI
- 14.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.